GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Kdm1a | decreases expression | ISO | KDM1A (Homo sapiens) | 6480464 | CTD | Valproic Acid results in decreased expression of KDM1A mRNA | PMID:19101580 | Kdm1a | multiple interactions | ISO | KDM1A (Homo sapiens) | 6480464 | CTD | [Valproic Acid co-treated with arsenic trioxide] results in increased expression of KDM1A mRNA; [Valproic Acid co-treated with arsenic trioxide] results in increased expression of KDM1A protein | PMID:25815518 | Kdm1a | multiple interactions | ISO | Kdm1a (Mus musculus) | 6480464 | CTD | KDM1A protein affects the reaction [Valproic Acid inhibits the reaction [Dexamethasone results in decreased expression of HBEGF mRNA]]; KDM1A protein affects the reaction [Valproic Acid inhibits the reaction [Dexamethasone results in decreased expression of HES1 mRNA]]; KDM1A protein affects the reaction [Valproic Acid inhibits the reaction [Dexamethasone results in decreased expression of IGSF9 mRNA]]; KDM1A protein affects the reaction [Valproic Acid inhibits the reaction [Dexamethasone results in decreased expression of RGS16 mRNA]] | PMID:27645313 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |